Obesity drugs
Zealand Pharma’s stock swings show weight-loss drug market’s new test
Survodutide’s dropout rates cooled enthusiasm, but investors are watching whether amylin-based petrelintide can offer a more tolerable obesity treatment
Read verified news on BetaVoices covering Amylin drugs, with reporting, context, and related developments.
Obesity drugs
Survodutide’s dropout rates cooled enthusiasm, but investors are watching whether amylin-based petrelintide can offer a more tolerable obesity treatment